Note: Ingredients listed on restricted chemical lists
EC/CAS
202-849-4/100-41-4
Name of the chemical
Ethylbenzene
Concentration
10 - 25
EC/CAS
200-751-6/71-36-3
Name of the chemical
1-butanol
Concentration
2,5 - 5
EC/CAS
203-625-9/108-88-3
Name of the chemical
Toluene
Concentration
0,1 - 1
General Information
Version
5.0
Revision date
2022-10-04
Product name
CFS-PRIM
1.2.1 Relevant identified uses
Professional use Industrial/Professional use spec
Emergency telephone
+41 44 251 51 51
Icons in SDS
Company Information
company name
Hilti France S.A.S
e-mail address of the competent person responsible for the Safety Data Sheet
fr-contactez-nous@hilti.com, chemicals.hse@hilti.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H315, H318, H332, H335, H336, H373
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Highly flammable liquid and vapour. May cause damage to organs through prolonged or repeated exposure. May cause drowsiness or dizziness. Harmful if inhaled. May cause respiratory irritation. Causes skin irritation. Causes serious eye damage.
2.2 Label elements
Labelling
Hazard pictograms
GHS02 GHS05 GHS07 GHS08
Signal word
Danger
Contains
Xylene, 2-Butanone, Ethylbenzene, 1-Butanol
Hazard statements
H225 - Highly flammable liquid and vapour. H315 - Causes skin irritation. H318 - Causes serious eye damage. H332 - Harmful if inhaled. H335 - May cause respiratory irritation. H336 - May cause drowsiness or dizziness. H373 - May cause damage to organs through prolonged or repeated exposure
Precautionary statements
P210 - Keep away from heat/sparks/open flames/hot surfaces. – No smoking. P280 - Wear eye protection, protective clothing, protective gloves. P302+P352 - IF ON SKIN Wash with plenty of soap and water. P304+P340 - IF INHALED Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305+P351+P338+P310 - IF IN EYES Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a doctor. P308+P313 - IF exposed or concerned Get medical advice/attention
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Xylene (1330-20-7) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII 2-Butanone (78-93-3) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Ethylbenzene (100-41-4) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII 1-Butanol (71-36-3) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII toluene (108-88-3) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component Xylene(1330-20-7) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 2-Butanone(78-93-3) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Ethylbenzene(100-41-4) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 1-Butanol(71-36-3) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 toluene(108-88-3) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605